Automated COVID symptom tracking in Parkinson's Disease
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-274
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Dr. Ravi VaidyanathanResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Individuals with multimorbidity
Occupations of Interest
Unspecified
Abstract
The impact of COVID-19 is acutely pronounced on patients suffering from Parkinson's Disease (PD) The majority of the 130,000+ UK patients are elderly, can suffer from respiratory complications, anxiety and depression. We propose to accelerate the development of an at-home Parkinson's Diagnostic Device (PDD) addressing this need to assist neurologists in telemedicine examination of PD patients for remote monitoring and subsequent updating of medication plans accordingly.